SCHEMBL385887

SCHEMBL385887

CCCC(=O)OC(=O)CC(C)(C)C

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.68
CES2 O00748 1/20 0.36
CES1 P23141 1/20 0.36
HDAC3 O15379 4/20 0.36
HDAC1 Q13547 4/20 0.36
HDAC2 Q92769 4/20 0.36
HDAC8 Q9BY41 4/20 0.36
HDAC6 Q9UBN7 1/20 0.36
FFAR3 O14843 3/20 0.35
LMNA P02545 2/20 0.34
TSHR P16473 1/20 0.33
MIF P14174 1/20 0.32
PRSS1 P07477 1/20 0.31
CTSG P08311 1/20 0.31
CTRB1 P17538 1/20 0.31
CMA1 P23946 1/20 0.31
NAAA Q02083 1/20 0.30
DGKA P23743 1/20 0.30
BCL9 O00512 1/20 0.30
CTNNB1 P35222 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16816741 0.87 ALDH1A1 (0.50) ALDH1A1CES2CES1LMNATSHR
SCHEMBL385886 0.85 ALDH1A1 (0.41) ALDH1A1FFAR3LMNATSHRMIF
SCHEMBL29022868 0.84 DGKA (0.52) ALDH1A1CES2CES1LMNATSHR
SCHEMBL10778369 0.84 DGKA (0.52) ALDH1A1CES2CES1LMNATSHR
SCHEMBL28781976 0.84 DGKA (0.52) ALDH1A1CES2CES1LMNATSHR
SCHEMBL182236 0.83 ALDH1A1 (0.42) ALDH1A1FFAR3LMNAMIFNAAA
SCHEMBL8374684 0.83 ALDH1A1 (0.62) ALDH1A1CES2CES1HDAC3HDAC1
SCHEMBL30568759 0.83 ALDH1A1 (1.00) ALDH1A1CES2CES1HDAC3HDAC1
SCHEMBL8158 0.83 ALDH1A1 (1.00) ALDH1A1CES2CES1HDAC3HDAC1
SCHEMBL27500855 0.80 ALDH1A1 (0.65) ALDH1A1CES2CES1HDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 249 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12620622-B2 Compound including sulfur-containing heterocyclic cation and bis(oxolato)borate anion, electrolytic solution and electrochemical device including the same DAIKIN INDUSTRIES, LTD. (JP) 2026-05-05 US disclosed
US-20250260063-A1 ELECTROLYTIC SOLUTION, ELECTROCHEMICAL DEVICE, SECONDARY BATTERY, AND LITHIUM-ION SECONDARY BATTERY DAIKIN INDUSTRIES, LTD. (JP) 2025-08-14 US disclosed
EP-3780232-B1 ELECTROLYTIC SOLUTION, ELECTROCHEMICAL DEVICE, LITHIUM-ION SECONDARY BATTERY, AND MODULE DAIKIN IND LTD (JP) 2025-07-30 EP disclosed
US-20250174720-A1 ELECTROLYTE, ELECTROCHEMICAL DEVICE, LITHIUM ION SECONDARY BATTERY, AND MODULE DAIKIN INDUSTRIES, LTD. (JP) 2025-05-29 US disclosed
US-12315885-B2 Electrolytic solution, electrochemical device, lithium-ion secondary battery, and module DAIKIN INDUSTRIES, LTD. (JP) 2025-05-27 US disclosed
EP-4553940-A1 SECONDARY BATTERY DAIKIN INDUSTRIES, LTD. (JP) 2025-05-14 EP disclosed
EP-4553918-A1 NEGATIVE ELECTRODE, BATTERY, AND METHOD FOR COVERING BATTERY MATERIAL DAIKIN INDUSTRIES, LTD. (JP) 2025-05-14 EP disclosed
EP-4546456-A1 SURFACE TREATMENT AGENT FOR ELECTRODE MATERIAL, POSITIVE ELECTRODE ACTIVE MATERIAL, CURRENT COLLECTOR FOIL, NEGATIVE ELECTRODE ACTIVE MATERIAL, CONDUCTIVE AID, ELECTRODE, BATTERY, METHOD FOR MANUFACTURING POSITIVE ELECTRODE ACTIVE MATERIAL, METHOD FOR MANUFACTURING CURRENT COLLECTOR FOIL, METHOD FOR MANUFACTURING NEGATIVE ELECTRODE ACTIVE MATERIAL, METHOD FOR MANUFACTURING CONDUCTIVE AID, AND METHOD FOR MANUFACTURING ELECTRODE DAIKIN INDUSTRIES, LTD. (JP) 2025-04-30 EP disclosed
US-20250132344-A1 SURFACE TREATMENT AGENT FOR ELECTRODE MATERIAL, POSITIVE ELECTRODE ACTIVE MATERIAL, CURRENT COLLECTOR FOIL, NEGATIVE ELECTRODE ACTIVE MATERIAL, CONDUCTIVE AID, ELECTRODE, BATTERY, METHOD FOR MANUFACTURING POSITIVE ELECTRODE ACTIVE MATERIAL, METHOD FOR MANUFACTURING CURRENT COLLECTOR FOIL, METHOD FOR MANUFACTURING NEGATIVE ELECTRODE ACTIVE MATERIAL, METHOD FOR MANUFACTURING CONDUCTIVE AID, AND METHOD FOR MANUFACTURING ELECTRODE DAIKIN INDUSTRIES, LTD. (JP) 2025-04-24 US disclosed
EP-4539193-A1 ELECTROLYTE SOLUTION AND SECONDARY BATTERY USING SAME DAIKIN INDUSTRIES, LTD. (JP) 2025-04-16 EP disclosed
WO-2006126717-A1 METHOD FOR PRODUCING THERMOPLASTIC FILM FUJIFILM CORPORATION (JP) 2006-11-30 WO disclosed
US-7125865-B2 Therapeutic compounds for treating dyslipidemic conditions MERCK & CO., INC. (US) 2006-10-24 US disclosed
US-20060222786-A1 Cellulose acylate, cellulose acylate film, and method for production and use thereof FUJI PHOTO FILM CO., LTD. (JP) 2006-10-05 US disclosed
US-20060221275-A1 Optical compensation sheet, polarizing plate and liquid crystal display FUJI PHOTO FILM CO., LTD. 2006-10-05 US disclosed
US-20060188667-A1 Optical cellulose acylate film and a method of manufacturing the same FUJI PHOTO FILM CO., LTD. (JP) 2006-08-24 US disclosed
US-20060066011-A1 Cellulose acylate film and process for producing the same, and optical film and image display device using the cellulose acylate film FUJI PHOTO FILM CO., LTD. 2006-03-30 US disclosed
US-20060004192-A1 Method of preparing a cellulose acylate, cellulose acylate film, polarizing plate, and liquid crystal display device FUJI PHOTO FILM CO., LTD. 2006-01-05 US disclosed
US-20050239769-A1 Therapeutic compounds for treating dyslipidemic conditions MERCK SHARP & DOHME CORP. 2005-10-27 US disclosed
EP-1534696-A1 THERAPEUTIC COMPOUNDS FOR TREATING DYSLIPIDEMIC CONDITIONS Merck & Co., Inc. (US) 2005-06-01 EP disclosed
WO-2004011448-A1 THERAPEUTIC COMPOUNDS FOR TREATING DYSLIPIDEMIC CONDITIONS MERCK & CO., INC. (US) 2004-02-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250174720-A1 ELECTROLYTE, ELECTROCHEMICAL DEVICE, LITHIUM ION SECONDARY BATTERY, AND MODULE HCN2, HCN1, HCN3 ALDH1A1 955/4885CES2 627/4885CES1 1303/4885
US-12620622-B2 Compound including sulfur-containing heterocyclic cation and bis(oxolato)borate anion, electrolytic solution and electrochemical device including the same ASH2L, OLA1, ODC1 ALDH1A1 1584/4885CES2 2389/4885CES1 2196/4885
US-20050239769-A1 Therapeutic compounds for treating dyslipidemic conditions NR1H2, NR1H3, LDLR ALDH1A1 1584/4885CES2 564/4885CES1 63/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.